Trial Profile
Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2019
Price :
$35
*
At a glance
- Drugs DA 9701 (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 20 May 2019 Status changed from active, no longer recruiting to completed.
- 03 Jun 2018 Planned End Date changed from 1 May 2018 to 1 Jun 2018.
- 03 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Jun 2018.